ALS drug from Denali, Sanofi falls short in mid-stage study
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen’s new CEO, Christopher Viehbacher, said the company is well positioned to return to sustainable growth.
BIIB earnings call for the period ending December 31, 2023.
BIIB earnings call for the period ending December 31, 2023.